Bayer has participated in the CIIE for nine consecutive years, bringing nearly 30 debut exhibits.

China News Service, Shanghai, October 5 (Reporter Chen Jing) "The China International Import Expo provides Bayer with an important platform for communication and cooperation, helping us to quickly transform innovation into tangible results that benefit patients, consumers and growers." Zhang Lei, Bayer's vice president of communications for Greater China and Northeast Asia, told reporters on the 5th, "In the face of continuous changes in the industry and market, companies need to continue to accelerate innovation and rethink how to better serve society."

On the 30-day countdown to the opening of the 9th China International Import Expo (CIIE), the reporter learned that as a "full-time student" participating in the CIIE, Bayer will attend the appointment again and bring nearly 30 "first-show debut" exhibits in three directions: prescription drugs (and imaging diagnostics), health consumer goods and crop science. Zhang Lei pointed out that Bayer always views its development in China with a long-term view. Participating in the CIIE for nine consecutive years is a reflection of the company’s firm confidence in China, a strategic market.

Over the past eight years, more and more innovations unveiled at the CIIE are moving from the exhibition booth to the real world. The CIIE has witnessed important nodes in Bayer's development in China: from the debut of innovative achievements to the accelerated implementation of innovative products, from the continuous deepening of individual cooperation to the gradual formation of an open innovation ecosystem, from accelerating the introduction of global innovation to helping local innovation go global.

This year, among the seven "debut" exhibits of Bayer's prescription drugs, Asundexian, a new product in the cardiovascular and cerebrovascular fields, will make its first public appearance after its marketing application in China was accepted. Bayer continues to promote the in-depth integration of China's innovation resources with its global innovation system, accelerating the transformation of innovation results from laboratories to industrial applications.

In addition, at this CIIE, eight new products from Bayer's consumer health department will have their own unique features. At the same time, focusing on the three major sectors of crop protection, corn seeds and vegetable seeds, innovative solutions and services that are closer to China's agricultural planting scenarios and actual needs will be displayed. Eight new Dika corn varieties will make their debut in China. (over)